Tornier, a global medical device company bought out by private equity firm Warburg Pincus that supplies replacement joints to extremity surgeons, filed on Tuesday with the SEC to raise up to $205 million in an initial public offering. The Netherlands-based company, which was founded in the 1940s and booked $212 million in sales for the 12 months ended April 4th, 2010, plans to list on the NASDAQ under the symbol TRNX. BofA Merrill Lynch and J.P. Morgan are the lead underwriters on the deal, for which pricing terms and timing were not disclosed.
